mifepristone has been researched along with Invasiveness, Neoplasm in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandhagen, BN; Goyeneche, AA; Ritch, SJ; Telleria, CM | 1 |
| Camacho-Arroyo, I; Cerbón, M; González-Arenas, A; Hansberg-Pastor, V; Piña-Medina, AG | 1 |
| He, S; Huang, C; Jia, L; Liu, J; Lu, Y; Qin, C; Tian, Z; Yan, C; Yang, X; Yu, S | 1 |
| Chen, H; Chen, J; Jia, L; Li, T; Liu, J; Liu, W; Wang, J; Zheng, N | 1 |
| Edwards, DP; Holley, AK; Jenkins, JT; Kiningham, KK; Moore, MR; Spitz, DR | 1 |
| Glazer, RI; Kopelovich, L; Lu, J; Upadhyay, G; Yuan, H | 1 |
| Brandhagen, BN; Goyeneche, AA; Telleria, CM; Tieszen, CR; Tracy, MS; Ulmer, TM | 1 |
| Leo, JC; Lin, VC | 1 |
| McDonnel, AC; Murdoch, WJ | 1 |
9 other study(ies) available for mifepristone and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Advanced assessment of migration and invasion of cancer cells in response to mifepristone therapy using double fluorescence cytochemical labeling.
Topics: Cell Movement; Cell Proliferation; Fluorescence; Hormone Antagonists; Humans; Mifepristone; Neoplasm Invasiveness; Neoplasms; Tumor Cells, Cultured; Wound Healing | 2019 |
Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells.
Topics: Actin Depolymerizing Factors; Astrocytoma; Cell Line, Tumor; Cell Movement; Humans; Mifepristone; Neoplasm Invasiveness; Phosphorylation; Progesterone; Receptors, Progesterone | 2016 |
Pharmacoproteomic analysis reveals that metapristone (RU486 metabolite) intervenes E-cadherin and vimentin to realize cancer metastasis chemoprevention.
Topics: Antigens, CD; Blotting, Western; Cadherins; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Shape; Cell Survival; Chemoprevention; Down-Regulation; Epithelial-Mesenchymal Transition; Gene Ontology; Human Umbilical Vein Endothelial Cells; Humans; Isotope Labeling; Metabolome; Mifepristone; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Proteomics; Reproducibility of Results; Up-Regulation; Vimentin | 2016 |
Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention.
Topics: Abortifacient Agents; Animals; Antineoplastic Agents; Carcinoma, Ovarian Epithelial; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chemokine CXCL12; Chemoprevention; Female; Humans; Mice, Inbred BALB C; Mice, Nude; Mifepristone; Neoplasm Invasiveness; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Ovary; Peritoneal Neoplasms; Peritoneum; Receptors, CXCR4; Signal Transduction | 2017 |
Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells.
Topics: Base Sequence; Breast Neoplasms; Butadienes; Cell Line, Tumor; DNA Primers; Female; Hormone Antagonists; Humans; MAP Kinase Signaling System; Mifepristone; Neoplasm Invasiveness; Nitriles; Progesterone Congeners; Promegestone; Receptors, Progesterone; RNA, Messenger; RNA, Neoplasm; RNA, Small Interfering; Superoxide Dismutase | 2009 |
The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Hormonal; Carcinogens; Carcinoma; Chemoprevention; Drug Evaluation, Preclinical; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Hormone Antagonists; Inflammation; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Microarray Analysis; Mifepristone; Neoplasm Invasiveness; Paired Box Transcription Factors; PAX8 Transcription Factor | 2012 |
Cytostasis and morphological changes induced by mifepristone in human metastatic cancer cells involve cytoskeletal filamentous actin reorganization and impairment of cell adhesion dynamics.
Topics: Actin Cytoskeleton; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cytostatic Agents; Female; Hormone Antagonists; Humans; Male; Mifepristone; Neoplasm Invasiveness; Neoplasms; Nervous System Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Time Factors | 2013 |
The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner.
Topics: Adenoviridae; Blotting, Western; Breast Neoplasms; Cell Cycle; Cell Division; Collagen; Drug Combinations; Female; Fluorescent Antibody Technique; Hormone Antagonists; Humans; Laminin; Ligands; Mifepristone; Neoplasm Invasiveness; Norpregnadienes; Polymerase Chain Reaction; Progesterone; Protein Isoforms; Proteoglycans; Receptors, Progesterone; Transfection; Tumor Cells, Cultured; Wound Healing | 2008 |
High-dose progesterone inhibition of urokinase secretion and invasive activity by SKOV-3 ovarian carcinoma cells: evidence for a receptor-independent nongenomic effect on the plasma membrane.
Topics: Adenocarcinoma; Cell Membrane; Dose-Response Relationship, Drug; Drug Interactions; Estradiol; Female; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Mifepristone; Neoplasm Invasiveness; Ovarian Neoplasms; Progesterone; Receptors, Progesterone; Testosterone; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 2001 |